Virus-based Tools: Lentivirus, AAV und VSV

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner BPS Bioscience offers infection systems based on lentiviruses, adeno-associated viruses (AAV) or the vesicular stomatitis virus (VSV). Lentiviruses can be used to generate stably transfected cell lines, they have a high infection rate (>90%), provide high levels of subsequent protein expression, and can be used both in vitro and in vivo. Learn more about lentiviruses and potential applications in our blog. AAVs are useful as viral vectors because they can carry a gene of interest up to 5 kb in length. Because they lead to stable gene expression and they can be used safely due to their low immunogenicity, AAVs are the vectors of choice for the development of many gene therapies. The enveloped VSV provides a valuable tool for studying viral entry, replication, and assembly. VSV-G, the glycoprotein of the virus, is responsible for the attachment and entry of VSVs into the host cell and is often used to pseudotype viral vectors.

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner  BPS Bioscience offers infection systems based on lentiviruses, adeno-associated... read more »
Close window
Virus-based Tools: Lentivirus, AAV und VSV

Virus-based tools can be used to manipulate genetic material and study viral infections. Our partner BPS Bioscience offers infection systems based on lentiviruses, adeno-associated viruses (AAV) or the vesicular stomatitis virus (VSV). Lentiviruses can be used to generate stably transfected cell lines, they have a high infection rate (>90%), provide high levels of subsequent protein expression, and can be used both in vitro and in vivo. Learn more about lentiviruses and potential applications in our blog. AAVs are useful as viral vectors because they can carry a gene of interest up to 5 kb in length. Because they lead to stable gene expression and they can be used safely due to their low immunogenicity, AAVs are the vectors of choice for the development of many gene therapies. The enveloped VSV provides a valuable tool for studying viral entry, replication, and assembly. VSV-G, the glycoprotein of the virus, is responsible for the attachment and entry of VSVs into the host cell and is often used to pseudotype viral vectors.

8 from 29 pages
No results were found for the filter!
COVID-19 Research
Spike (beta B.1.351 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)
Spike (beta B.1.351 Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78142-1

The Spike (SARS-CoV-2) (B.1.351) Pseudotyped Lentivirus were produced with SARS-CoV-2 B.1.351 Variant Spike (Genbank Accession #QHD43416.1 with B.1.351 mutations (L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G, A701V) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,285.00€ *
Review
COVID-19 Research
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)
Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78143-1

The Spike (K417T, E484K, N501Y) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank Accession #QHD43416.1 with mutations K417T, E484K, and N501Y) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly luciferase gene driven by...
Keywords: 2, K417T, E484K, N501Y
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
COVID-19 Research
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78144-1

In Brazil, a variant called P.1 was first identified in the summer of 2020. This variant has many mutations that may lead to higher transmissibility and infectivity. The Spike (P.1) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 Variant Spike (Genbank #QHD43416.1 with P.1 mutations (L18F, T20N,...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
COVID-19 Research
Spike (alpha B.1.1.7 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (alpha B.1.1.7 Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78158-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
COVID-19 Research
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (gamma P.1 Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78159-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
COVID-19 Research
Spike (beta B.1.351 Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)
Spike (beta B.1.351 Variant) (SARS-CoV-2) Pseudotyped...

Item number: BPS-78160-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
NF-kappaB eGFP Reporter Lentivirus
NF-kappaB eGFP Reporter Lentivirus

Item number: BPS-79926

The NF-kappaB eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced GFP gene driven by the NF-kappaB response element located...
Keywords: NF-kappaB reporter, NFkappaB pseudovirion, nfkb pseudovirus, NF-kappaB lenti, NFkB lentivirus,
Application: NFkB signaling pathway activator/inhibitor screening, NFkB eGFP reporter stable cell line generation
Species reactivity: human
1,285.00€ *
Review
Firefly Luciferase-eGFP Lentivirus (Puromycin)-79980-P
Firefly Luciferase-eGFP Lentivirus (Puromycin)-79980-P

Item number: BPS-79980-P

The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and eGFP cassette (Luc-P2A-eGFP) driven by...
Keywords: GFP, Green fluorescent protein,
Application: Positive control/transduction, transduction optimization
Species reactivity: mammalian
1,373.00€ *
Review
Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus (Luc Reporter)
Spike (Epsilon B.1.429 Variant) Pseudotyped Lentivirus...

Item number: BPS-78172-1

The Spike (Epsilon B.1.429 Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 B.1.429 Variant Spike (Genbank Accession #QHD43416.1 with B.1.429 variant mutations, see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the firefly...
Keywords: 2,
Application: Viral transduction studies, neutralizing antibody screening
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
Spike (B.1.617 Delta/Kappa Parental Variant) Pseudotyped Lentivirus (Luc Reporter)
Spike (B.1.617 Delta/Kappa Parental Variant) Pseudotyped...

Item number: BPS-78204-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Coronavirus studies
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
Spike (B.1.617.1 Kappa Variant) Pseudotyped Lentivirus (Luc Reporter)
Spike (B.1.617.1 Kappa Variant) Pseudotyped Lentivirus...

Item number: BPS-78205-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Coronavirus studies
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
Spike (B.1.618 Variant) Pseudotyped Lentivirus (Luc Reporter)
Spike (B.1.618 Variant) Pseudotyped Lentivirus (Luc...

Item number: BPS-78206-1

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting...
Keywords: 2,
Application: Coronavirus studies
Species reactivity: SARS-CoV-2
From 1,248.00€ *
Review
8 from 29 pages